Back to search

Article

Regulatory approved monoclonal antibodies contain framework mutations predicted from human antibody repertoires

2021-06-22

Abstract excerpt

Monoclonal antibodies (mAbs) are an important class of therapeutics used to treat cancer, inflammation, and infectious diseases. Identifying highly developable mAb sequences in silico could greatly reduce the time and cost required for therapeutic mAb development. Here, we present position-specific scoring matrices (PSSMs) for antibody framework mutations developed using natural human antibody repertoire sequence...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b874321b-01dc-5872-ad41-7c7ded5506e7
DOI
10.1101/2021.06.22.449488
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Regulatory approved monoclonal antibodies contain framework mutations predicted from human antibody repertoiresDOI 10.1101/2021.06.22.449488
Select a neighboring publication to make it the new centre.